好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Temozolamide/Bevacizumab for the Treatment of a Patient with Progressive Myxopapillary Ependymoma
Neuro-oncology
(-)
023
Authors/Disclosures
Karl M. Meisel, MD (McLaren Northern) No disclosure on file
Helen Shih (MGH) No disclosure on file
Angela Y. Peters, MD (University of Utah) The institution of Dr. Peters has received research support from NIH.
No disclosure on file
Suriya A. Jeyapalan, MD, MPH (Tufts Medical Center) Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Jeyapalan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure.
Paul Frohna, MD, PhD, PharmD (Bioniz Therapeutics, Inc) No disclosure on file